We are live on ! Find out more
ZURA icon

Zura Bio

45 hedge funds and large institutions have $37.6M invested in Zura Bio in 2024 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 14 increasing their positions, 19 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 4

2% more funds holding

Funds holding: 4445 (+1)

0.65% less ownership

Funds ownership: 34.82%34.17% (-0.65%)

26% less repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 19

47% less capital invested

Capital invested by funds: $70.7M → $37.6M (-$33.1M)

Holders
45
Holders Change
+1
Holders Change %
+2.27%
% of All Funds
0.65%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
14
Reduced
19
Closed
4
Calls
Puts
Net Calls
Net Calls Change

ZURA Hedge Fund Activity: Q1 2024 in Review

45 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in Zura Bio (ZURA) for Q1 2024, worth a combined $37.6M — down 47% from $70.7M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new ZURA positions and 4 closed out — a net gain of 1 holder — while 14 added to existing stakes and 19 trimmed.

The largest buyer was Affinity Asset Advisors, opening a new position worth an estimated $1.59M. The largest seller was Great Point Partners, cutting an estimated $1.9M.

  • 45 institutional investors held Zura Bio (ZURA) as of Q1 2024, up from 44 in Q4 2023.
  • Funds reported $37.6M of Zura Bio stock for Q1 2024, down 47% quarter-over-quarter.
  • 5 funds opened new Zura Bio positions in Q1 2024 and 4 closed out, a net change of +1 holder.
  • The largest Zura Bio buyer in Q1 2024 was Affinity Asset Advisors, an estimated $1.59M added.
  • The largest Zura Bio seller in Q1 2024 was Great Point Partners, an estimated $1.9M sold.

Based on aggregated 13F filings for Q1 2024.